Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Prime Medicine, Inc. made a total of 15 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $3.84
Date | Dividend | Adj Dividend |
---|---|---|
September 10, 19 | $0.80 | $0.80 |
June 14, 19 | $0.20 | $0.20 |
December 18, 18 | $0.21 | $0.21 |
September 14, 18 | $0.23 | $0.23 |
June 21, 18 | $0.15 | $0.15 |
March 22, 18 | $0.01 | $0.01 |
December 21, 17 | $0.86 | $0.86 |
September 21, 17 | $0.07 | $0.07 |
June 22, 17 | $0.11 | $0.11 |
March 23, 17 | $0.03 | $0.03 |
December 21, 16 | $0.73 | $0.73 |
September 21, 16 | $0.17 | $0.16 |
June 22, 16 | $0.17 | $0.17 |
March 23, 16 | $0.02 | $0.02 |
December 23, 15 | $0.09 | $0.09 |